A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).
Clinical trial NCT00435825 · COMPLETED
Trial details
- NCT number
- NCT00435825
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-12-01
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.